MedTrace Logo

EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients

NCT01402154 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 361

Last updated 2021-08-05

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the predictive value (in terms of remission) of a new technique for detecting circulating, functional, prostate cells among patients with localized adenocarcinoma of the prostate, and prior to any treatment.

Conditions

  • Adenocarcinoma of the Prostate

Interventions

BIOLOGICAL

EPISPOT detection of the number of circulating cells

EPISPOT detection of the number of circulating, functional, prostate cells per unit blood

BIOLOGICAL

CellSearch detection of the number of circulating, functional, prostate cells

CellSearch detection of the number of circulating, functional, prostate cells per unit blood

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Stéphane Droupy, MD PhD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-03
Primary Completion
2014-12-08
Completion
2021-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01402154 on ClinicalTrials.gov